Cargando…
CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice
Several studies have shown a reduced efficacy of influenza vaccines in the elderly compared to young adults. In this study, we evaluated the immunogenicity and protective efficacy of a commercially available inactivated influenza vaccine (Fluzone(®)) in young adult and aged mice. C57/BL6 mice were a...
Autores principales: | Ramirez, Alejandro, Co, Mary, Mathew, Anuja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774967/ https://www.ncbi.nlm.nih.gov/pubmed/26934728 http://dx.doi.org/10.1371/journal.pone.0150425 |
Ejemplares similares
-
Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant
por: Kang, Xinliang, et al.
Publicado: (2022) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
por: Li, Yibo, et al.
Publicado: (2023) -
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
por: Shirai, Seiki, et al.
Publicado: (2020) -
Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
por: Soema, Peter C., et al.
Publicado: (2014)